Javascript must be enabled to continue!
Effect of smoking on clinical outcomes of hospitalised female smokers with acute myocardial infarction
View through CrossRef
Background
Although the prevalence of smoking among Chinese women was 2.4%, it is still increasing in many cities. Smoking is known to be a strong risk factor for premature atherosclerosis, acute myocardial infarction (AMI) and sudden cardiac death. Up to date, the relation between smoking and AMI in Chinese female smokers is still unclear. This study described the baseline characteristics for female smokers hospitalised with AMI and investigated the effects of cigarette smoking on their clinical outcomes.
Methods
A total of 393 women aged 18 years or over with AMI was prospectively recruited from 1 January 2007 to 31 December of 2009 from a tertiary hospital. Patients were grouped into smokers and non-smokers. The relationships between baseline characteristics and clinical outcomes were tested using either the χ2 test for trend for discrete variables or analysis of variance for continuous variables.
Results
Smokers accounted for 100 (25.4%) with the significantly lower prevalence of hypertension, diabetes mellitus and hyperlipidaemia than non-smokers (p<0.05). The proportion of premenopausal smokers was higher compared to premenopausal non-smoker, (11% vs 3.4%, p=0.006). The smokers were average 1.3 years younger than non-smokers with no significant difference (65.89±10.72 vs 67.18±9.10 p=0.243). However, when all patients with any other cardiovascular risk factors such as hypertension, diabetes mellitus and hyperlipidemia were removed, in the left smokers were average 4.7 years younger than non-smokers with significant difference (64.37±12.24 vs 69.11±9.54, p=0.036), and had the lower rate of effort angina before the first AMI (14% vs 39.6%, p=0.005), had the higher rate of TIMI flow grade 2 or 3 after thrombolytic therapy (50.0% vs 16.7%, p=0.008) and severe arrhythmia (14.0% vs 1.9%, p=0.043). The heart failure rate and mortality of the smokers with or without the other cardiovascular risk factors had no significant difference compared to non-smokers (respectively 2.3% vs 3.8%, p=0.579; 14% vs 13.2%, p=0.915).
Conclusion
Smoking is a strong risk factor that results in earlier AMI in female smokers with less other cardiovascular risk factors; female smokers with first AMI had no better clinical outcomes than non-smokers.
Title: Effect of smoking on clinical outcomes of hospitalised female smokers with acute myocardial infarction
Description:
Background
Although the prevalence of smoking among Chinese women was 2.
4%, it is still increasing in many cities.
Smoking is known to be a strong risk factor for premature atherosclerosis, acute myocardial infarction (AMI) and sudden cardiac death.
Up to date, the relation between smoking and AMI in Chinese female smokers is still unclear.
This study described the baseline characteristics for female smokers hospitalised with AMI and investigated the effects of cigarette smoking on their clinical outcomes.
Methods
A total of 393 women aged 18 years or over with AMI was prospectively recruited from 1 January 2007 to 31 December of 2009 from a tertiary hospital.
Patients were grouped into smokers and non-smokers.
The relationships between baseline characteristics and clinical outcomes were tested using either the χ2 test for trend for discrete variables or analysis of variance for continuous variables.
Results
Smokers accounted for 100 (25.
4%) with the significantly lower prevalence of hypertension, diabetes mellitus and hyperlipidaemia than non-smokers (p<0.
05).
The proportion of premenopausal smokers was higher compared to premenopausal non-smoker, (11% vs 3.
4%, p=0.
006).
The smokers were average 1.
3 years younger than non-smokers with no significant difference (65.
89±10.
72 vs 67.
18±9.
10 p=0.
243).
However, when all patients with any other cardiovascular risk factors such as hypertension, diabetes mellitus and hyperlipidemia were removed, in the left smokers were average 4.
7 years younger than non-smokers with significant difference (64.
37±12.
24 vs 69.
11±9.
54, p=0.
036), and had the lower rate of effort angina before the first AMI (14% vs 39.
6%, p=0.
005), had the higher rate of TIMI flow grade 2 or 3 after thrombolytic therapy (50.
0% vs 16.
7%, p=0.
008) and severe arrhythmia (14.
0% vs 1.
9%, p=0.
043).
The heart failure rate and mortality of the smokers with or without the other cardiovascular risk factors had no significant difference compared to non-smokers (respectively 2.
3% vs 3.
8%, p=0.
579; 14% vs 13.
2%, p=0.
915).
Conclusion
Smoking is a strong risk factor that results in earlier AMI in female smokers with less other cardiovascular risk factors; female smokers with first AMI had no better clinical outcomes than non-smokers.
Related Results
Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non‐smokers
Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non‐smokers
AbstractBackground/aims: This study aimed to investigate the concentration of the cytokine interleukin (IL)‐1β and its receptor antagonist IL‐1ra in gingival crevicular fluid (GCF...
Abstract P338: Differences in Costs, Length of Stay and Mortality for Myocardial Infarction and Related Disorders in Non Federal Hospitals
Abstract P338: Differences in Costs, Length of Stay and Mortality for Myocardial Infarction and Related Disorders in Non Federal Hospitals
BACKGROUND:
Validated estimates of costs, length of stay, and mortality rates are necessary for the treatment and prevention of acute myocardial infarction in patient a...
Innate immunity and its link to clinical outcomes in smokers with and without COPD
Innate immunity and its link to clinical outcomes in smokers with and without COPD
<p dir="ltr">Chronic obstructive pulmonary disease (COPD) is the fourth most common causes of death globally, affecting around ten percent of the adult population. Patients w...
Innate immunity and its link to clinical outcomes in smokers with and without COPD
Innate immunity and its link to clinical outcomes in smokers with and without COPD
<p dir="ltr">Chronic obstructive pulmonary disease (COPD) is the fourth most common causes of death globally, affecting around ten percent of the adult population. Patients w...
Varenicline Versus Cytisine for Smoking Cessation in a Primary Care Setting: A Randomized Controlled Trial
Varenicline Versus Cytisine for Smoking Cessation in a Primary Care Setting: A Randomized Controlled Trial
Abstract
Our study aims to implement a smoking cessation program using pharmacotherapy in a real-life setting — primary care practices in Croatia and Slovenia — and...
Phagocytic Function of Salivary PMN After Smoking or Secondary Smoking
Phagocytic Function of Salivary PMN After Smoking or Secondary Smoking
AbstractAlterations in polymorphonuclear leukocyte (PMN) functions, such as phagocytosis, Chemotaxis, and oxidative burst, play a pivotal role in periodontal pathogenesis. In addit...
INFLUENCE OF SMOKING BAN IN EATERIES ON SMOKING ATTITUDES AMONG ADULT SMOKERS IN KLANG VALLEY MALAYSIA
INFLUENCE OF SMOKING BAN IN EATERIES ON SMOKING ATTITUDES AMONG ADULT SMOKERS IN KLANG VALLEY MALAYSIA
The objective of this study was to determine the effect of smoking ban in eateries on smoking behaviors and intention to quit smoking among adult smokers in Klang Valley. A validat...
THE CLINICAL VALUE OF MYOCARDIAL ENZYMES AND TROPONIN I COMBINED DETECTION FOR EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION
THE CLINICAL VALUE OF MYOCARDIAL ENZYMES AND TROPONIN I COMBINED DETECTION FOR EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION
Objectives
To investigate the clinical value of myocardial enzymes and troponin I combined detection for early diagnosis of acute myocardial infarction.
...

